Background: Sublingual immunotherapy (SLIT) is a safe/well-tolerated alternative to allergen injection immunotherapy for allergic rhinoconjunctivitis (ARC). Patient adherence is essential and patient-related outcome measures including treatment satisfaction are informative/indicative of adherence.
Objective: The aim was to assess treatment satisfaction with five-grass pollen tablet SLIT under real-life conditions.